Miriam Rosás-Umbert (Miriam Rosas-Umbert)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Men Who Have Sex With Men

Antiretroviral Therapy

Human Immunodeficiency Virus

Top Venues

Nature medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Àlex Olvera, Luis Romero-Martin, Bruna Oriol-Tordera, Miriam Rosás-Umbert, Tuixent Escribà, Beatriz Mothe, Christian Brander
Impact of ChAdOx1 or DNA Prime Vaccination on Magnitude, Breadth, and Focus of MVA-Boosted Immunogen-Specific T Cell Responses. Vaccines 12 (3) (2024)
Àlex Olvera, Luis Romero-Martin, Bruna Oriol-Tordera, Miriam Rosás-Umbert, Tuixent Escribà, Beatriz Mothe, Christian Brander
Impact of ChAdOx1 or DNA Prime Vaccination on Magnitude, Breadth, and Focus of MVA-Boosted Immunogen-Specific T Cell Responses. Vaccines 12 (3) (2024)
Àlex Olvera, Luis Romero-Martin, Bruna Oriol-Tordera, Miriam Rosás-Umbert, Tuixent Escribà, Beatriz Mothe, Christian Brander
Impact of ChAdOx1 or DNA Prime Vaccination on Magnitude, Breadth, and Focus of MVA-Boosted Immunogen-Specific T Cell Responses. Vaccines 12 (3) (2024)
Jesper Damsgaard Gunst, Jesper Falkesgaard Højen, Marie H Pahus, Miriam Rosás-Umbert, Birgitte Stiksrud, James H McMahon, Paul W Denton, Henrik Nielsen, Isik Somuncu Johansen, Thomas Benfield, Steffen Leth, Jan Gerstoft, Lars Østergaard, Mariane Høgsbjerg Schleimann, Rikke Olesen, Henrik Støvring, Line K Vibholm, Nina Weis, Anne Margarita Dyrhol-Riise, Karen B H Pedersen, Jillian S Y Lau, Dennis C Copertino, Noemi Linden, Tan T Huynh, Victor Ramos, R Brad Jones, Sharon R Lewin, Martin Tolstrup, Thomas A Rasmussen, Michel C Nussenzweig, Marina Caskey, Dag Henrik Reikvam, Ole Schmeltz Søgaard
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial. Nature medicine (2023)
Miriam Rosás-Umbert, Jesper Damsgaard Gunst, Marie H Pahus, Rikke Olesen, Mariane Høgsbjerg Schleimann, Paul W Denton, Victor Ramos, Adam R Ward, Natalie N Kinloch, Dennis C Copertino, Tuixent Escribà, Anuska Llano, Zabrina L Brumme, R Brad Jones, Beatriz Mothe, Christian Brander, Julie M Fox, Michel C Nussenzweig, Sarah Fidler, Marina Caskey, Martin Tolstrup, Ole Schmeltz Søgaard
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8 + T cell immunity. Nature communications 13 (1) (2022)
Jesper Damsgaard Gunst, Marie H Pahus, Miriam Rosás-Umbert, I-Na Lu, Thomas Lars Benfield, Henrik Nielsen, Isik S Johansen, Rajesh Mohey, Lars Østergaard, Vibeke Klastrup, Maryam Khan, Mariane H Schleimann, Rikke Olesen, Henrik Støvring, Paul W Denton, Natalie N Kinloch, Dennis C Copertino, Adam R Ward, Winiffer D Conce Alberto, Silke D Nielsen, Maria C Puertas, Victor Ramos, Jacqueline D Reeves, Christos J Petroupoulos, Javier Martínez Picado, Zabrina L Brumme, R Brad Jones, Julie Fox, Martin Tolstrup, Michel C Nussenzweig, Marina Caskey, Sarah Fidler, Ole Schmeltz Søgaard
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial. Nature medicine 28 (11) (2022)
Lucia Bailón, Anuska Llano, Samandhy Cedeño, Tuixent Escribà, Miriam Rosás-Umbert, Mariona Parera, Maria Casadellà, Miriam Lopez, Francisco Pérez, Bruna Oriol-Tordera, Marta Ruiz-Riol, Josep Coll, Felix Perez, Àngel Rivero, Anne R Leselbaum, Ian Michael McGowan, Devi Sengupta, Edmund G Wee, Tomáš Hanke, Roger Paredes, Yovaninna Alarcón-Soto, Bonaventura Clotet Sala, Marc Noguera-Julian, Christian Brander, Jose Molto, Beatriz Mothe, null null
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial. Nature medicine (2022)